Zobrazeno 1 - 10
of 361
pro vyhledávání: '"Iris Lansdorp – Vogelaar"'
Autor:
Fleur E. Marijnissen, Pieter J. F. de Jonge, Nicole S. Erler, Sohal Y. Ismail, Iris Lansdorp-Vogelaar, Manon C. W. Spaander
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Currently all participants of the Dutch colorectal cancer (CRC) screening program with a positive faecal immunochemical test (FIT) are seen at the outpatient clinic to assess their health status, receive information on colonoscopy
Externí odkaz:
https://doaj.org/article/6b7cfb8b92a34d4ea1c674f2e7f0ee85
Autor:
Kevin Selby, Iris Lansdorp-Vogelaar, Douglas A Corley, Jean-Luc Bulliard, Luuk A van Duuren, Ella Mohr, Rosita van den Puttelaar, Ekaterina Plys, Karen Brändle, Florian Froehlich
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Objective In 2019, a BMJ Rapid Recommendation advised against colorectal cancer (CRC) screening for adults with a predicted 15-year CRC risk below 3%. Using Switzerland as a case study, we estimated the population-level impact of this recommendation.
Externí odkaz:
https://doaj.org/article/c6de9f9a2d294a9c9db2fec036aad006
Autor:
Minta Thomas, Yu-Ru Su, Elisabeth A. Rosenthal, Lori C. Sakoda, Stephanie L. Schmit, Maria N. Timofeeva, Zhishan Chen, Ceres Fernandez-Rozadilla, Philip J. Law, Neil Murphy, Robert Carreras-Torres, Virginia Diez-Obrero, Franzel J. B. van Duijnhoven, Shangqing Jiang, Aesun Shin, Alicja Wolk, Amanda I. Phipps, Andrea Burnett-Hartman, Andrea Gsur, Andrew T. Chan, Ann G. Zauber, Anna H. Wu, Annika Lindblom, Caroline Y. Um, Catherine M. Tangen, Chris Gignoux, Christina Newton, Christopher A. Haiman, Conghui Qu, D. Timothy Bishop, Daniel D. Buchanan, David R. Crosslin, David V. Conti, Dong-Hyun Kim, Elizabeth Hauser, Emily White, Erin Siegel, Fredrick R. Schumacher, Gad Rennert, Graham G. Giles, Heather Hampel, Hermann Brenner, Isao Oze, Jae Hwan Oh, Jeffrey K. Lee, Jennifer L. Schneider, Jenny Chang-Claude, Jeongseon Kim, Jeroen R. Huyghe, Jiayin Zheng, Jochen Hampe, Joel Greenson, John L. Hopper, Julie R. Palmer, Kala Visvanathan, Keitaro Matsuo, Koichi Matsuda, Keum Ji Jung, Li Li, Loic Le Marchand, Ludmila Vodickova, Luis Bujanda, Marc J. Gunter, Marco Matejcic, Mark A. Jenkins, Martha L. Slattery, Mauro D’Amato, Meilin Wang, Michael Hoffmeister, Michael O. Woods, Michelle Kim, Mingyang Song, Motoki Iwasaki, Mulong Du, Natalia Udaltsova, Norie Sawada, Pavel Vodicka, Peter T. Campbell, Polly A. Newcomb, Qiuyin Cai, Rachel Pearlman, Rish K. Pai, Robert E. Schoen, Robert S. Steinfelder, Robert W. Haile, Rosita Vandenputtelaar, Ross L. Prentice, Sébastien Küry, Sergi Castellví-Bel, Shoichiro Tsugane, Sonja I. Berndt, Soo Chin Lee, Stefanie Brezina, Stephanie J. Weinstein, Stephen J. Chanock, Sun Ha Jee, Sun-Seog Kweon, Susan Vadaparampil, Tabitha A. Harrison, Taiki Yamaji, Temitope O. Keku, Veronika Vymetalkova, Volker Arndt, Wei-Hua Jia, Xiao-Ou Shu, Yi Lin, Yoon-Ok Ahn, Zsofia K. Stadler, Bethany Van Guelpen, Cornelia M. Ulrich, Elizabeth A. Platz, John D. Potter, Christopher I. Li, Reinier Meester, Victor Moreno, Jane C. Figueiredo, Graham Casey, Iris Lansdorp Vogelaar, Malcolm G. Dunlop, Stephen B. Gruber, Richard B. Hayes, Paul D. P. Pharoah, Richard S. Houlston, Gail P. Jarvik, Ian P. Tomlinson, Wei Zheng, Douglas A. Corley, Ulrike Peters, Li Hsu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Polygenic risk scores (PRS) have great potential to guide precision colorectal cancer (CRC) prevention by identifying those at higher risk to undertake targeted screening. However, current PRS using European ancestry data have sub-optimal pe
Externí odkaz:
https://doaj.org/article/e7a280372db24e62a96e2b247dd52766
Autor:
Lily C. Taylor, Rebecca A. Dennison, Simon J. Griffin, Stephen D. John, Iris Lansdorp-Vogelaar, Chloe V. Thomas, Rae Thomas, Juliet A. Usher-Smith
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Population-based cancer screening programmes are shifting away from age and/or sex-based screening criteria towards a risk-stratified approach. Any such changes must be acceptable to the public and communicated effectively. We aim
Externí odkaz:
https://doaj.org/article/3199571ed5f2425397f089b2fa10d02b
Autor:
Fleur E. Marijnissen, Pieter J. F. de Jonge, Nicole S. Erler, Sohal Y. Ismail, Iris Lansdorp-Vogelaar, Manon C. W. Spaander
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/13558935cebd4023b9d97b661459de97
Autor:
Esther Toes-Zoutendijk, Lucie de Jonge, Emilie C.H. Breekveldt, Ida J. Korfage, Juliet A. Usher-Smith, Iris Lansdorp-Vogelaar, Rebecca A. Dennison
Publikováno v:
Preventive Medicine Reports, Vol 35, Iss , Pp 102325- (2023)
Prior faecal Hemoglobin (f-Hb) concentrations of a negative fecal immunochemical test (FIT) can be used for risk stratification in colorectal cancer (CRC) screening. Individuals with higher f-Hb concentrations may benefit from a shorter screening int
Externí odkaz:
https://doaj.org/article/bc4eb558599246f8b88df16afbfdf810
Autor:
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background In 2014, the national population-based colorectal cancer (CRC) screening program was implemented in the Netherlands. Biennial fecal immunochemical testing (FIT) for hemoglobin (Hb) is used at a cut-off of 47 µg Hb per gram feces.
Externí odkaz:
https://doaj.org/article/71f5004844c04b1dbb3dcc68d0adf6e4
Autor:
Ekaterina Plys, Jean-Luc Bulliard, Aziz Chaouch, Marie-Anne Durand, Luuk A van Duuren, Karen Brändle, Reto Auer, Florian Froehlich, Iris Lansdorp-Vogelaar, Douglas A Corley, Kevin Selby
Publikováno v:
JMIR Research Protocols, Vol 12, p e46865 (2023)
BackgroundIncidence of and mortality from colorectal cancer (CRC) can be effectively reduced by screening with the fecal immunochemical test (FIT) or colonoscopy. Individual risk to develop CRC within 15 years varies from 15% among people aged 50 to
Externí odkaz:
https://doaj.org/article/da232728dc354a5989ade00967306e96
Autor:
Joachim Worthington, Francine van Wifferen, Zhuolu Sun, Lucie de Jonge, Jie-Bin Lew, Marjolein J.E. Greuter, Rosita van den Puttelaar, Eleonora Feletto, Iris Lansdorp-Vogelaar, Veerle M.H. Coupé, Jean Hai Ein Yong, Karen Canfell
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102081- (2023)
Summary: Background: Screening for colorectal cancer (CRC) decreases cancer burden through removal of precancerous lesions and early detection of cancer. The COVID-19 pandemic has disrupted organised CRC screening programs worldwide, with some progra
Externí odkaz:
https://doaj.org/article/2e680a2691694b27b4ace8c9bec48d4f
Autor:
Pedro Nascimento de Lima, Rosita van den Puttelaar, Anne I Hahn, Matthias Harlass, Nicholson Collier, Jonathan Ozik, Ann G Zauber, Iris Lansdorp-Vogelaar, Carolyn M Rutter
Publikováno v:
eLife, Vol 12 (2023)
The aftermath of the initial phase of the COVID-19 pandemic may contribute to the widening of disparities in colorectal cancer (CRC) outcomes due to differential disruptions to CRC screening. This comparative microsimulation analysis uses two CISNET
Externí odkaz:
https://doaj.org/article/c6dbf8e0e6864d758fd5299ab919e4f0